top of page
Contact Us
Home
About Us
First Product to Market
Advantages
Our lead product:
PL-Ex1 Placenta MSC derived EVs (PL-Ex) loaded with miR-124
PL-Ex1 targets
solid cancers
PL-Ex1 targets multiple oncogenic
pathways
Want to know more?
Get in touch
Home
About Us
First Product to Market
Advantages
Contact Us
bottom of page